You just read:

New TAILORx Data, Published Today in JAMA Oncology, Add to Strong Evidence Base Reinforcing Unique Ability of Oncotype DX Breast Recurrence Score® Test to Guide Chemotherapy Treatment

News provided by

Genomic Health, Inc.

30 Sep, 2019, 14:00 BST